课题基金 / 基金详情

DEVELOPING A SAFE, NUTRITIONAL SUPPLEMENT FOR CHILDREN WITH DRY SKIN & ECZEMA

DEVELOPING A SAFE, NUTRITIONAL SUPPLEMENT FOR CHILDREN WITH DRY SKIN & ECZEMA
为干性皮肤儿童开发安全、营养的补充剂
批准号:
102942
负责人:
金额:
$23.5万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Curapel® is a skin healthcare company that is developing patented products to help people with common, chronic and distressing skin conditions such as eczema and psoriasis. All Curapel's products contain natural and safe active ingredients which were identified by researchers at the the University of Manchester. The Curapel Philosophy is simple, we intend to develop successful products based on these technologies that work effectively with skin biology to 'Heal Skin Safely'. Eczema is one of the most common skin conditions that is six times more common in young children aged 1-5 years (~20%) than in adults (~3%). Unfortunately, current products for this distressing condition either just soothe the skin (emollients) or are medicines such as steroid creams that have extremely harsh side effects, especially when used by young children suffering from a chronic skin condition Curapel is now developing HISTIMEX as a safe, easy to use, once a day, oral nutritional supplement that provides a vital building block to restore a healthy skin barrier across the whole body. HISTIMEX has been tested in adults and has a similar effect as a middle-strength steroid cream but without any of the side effects. Curapel is now asking Innovate UK to help fund the testing of a new young child-friendly version of HISTIMEX in a clinical study in 1-5 year old children with eczema. When we have shown the effectiveness of this new children's HISTIMEX, we aim to launch it in 2017 as a safe product for young eczema sufferers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
叶绿体蛋白SAFE1和SAFE2介导单线态氧信号转导的机理研究
  • 批准号:
    32170284
  • 项目类别:
    面上项目
  • 资助金额:
    60万元
  • 批准年份:
    2021
  • 负责人:
    王良省
  • 依托单位:
基于Safe screening的多任务稀疏学习理论与算法的研究
  • 批准号:
    12071475
  • 项目类别:
    面上项目
  • 资助金额:
    51.0万元
  • 批准年份:
    2020
  • 负责人:
    徐义田
  • 依托单位:
醛糖还原酶(AR)激活SAFE(JAKs/STATs)通路在抵抗下颌下腺缺血再灌注损伤中的作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    张思恩
  • 依托单位:
基于Safe screening 的支持向量机的稀疏理论及其快速求解方法
  • 批准号:
    11671010
  • 项目类别:
    面上项目
  • 资助金额:
    48.0万元
  • 批准年份:
    2016
  • 负责人:
    徐义田
  • 依托单位: